AI drug developer Insilico Medicine has returned to the Hong Kong public markets with an updated IPO prospectus, targeting about $292 million in proceeds. The submission …
Read More
Bioptimus has announced M-Optimus, a foundation model trained on multimodal biomedical data including histology, bulk and spatial transcriptomics, and clinical records, aiming to simulate biological …
Read More
Biotechnology has revolutionized the healthcare industry, and with the increasing demand for advanced therapies, the focus has shifted towards innovative therapeutic modalities. In this blog …
Read More
Latent Labs, which emerged from stealth earlier this year with $50 million in funding, has announced Latent-X2, a generative AI model that produces antibody and …
Read More
OpenAI-backed Chai Discovery, founded in 2024, has raised $130M in a Series B round, valuing the company at $1.3B and bringing total funding to $225M …
Read More
The brain–computer interface (BCI) technology domain is constantly progressing as researchers and companies collaborate to devise inventive solutions that connect the human brain with external …
Read More
